Canadian Biotech Delivering Solutions to Global Marketplace

Reinventing traditional industries, Canadian innovation on display at
BIO World Congress on Industrial Biotechnology in Montreal July 24-26

OTTAWA, Ontario–(BUSINESS WIRE)–Today’s global population is closing in on the 7 billion mark. By 2050
it is predicted to grow to over 9 billion people. This exponential
growth brings with it enormous challenges as 9 billion people will
require new medicines, food, energy, and material goods. This growth and
its corresponding demands, require more efficient and effective ways to
deliver health care, grow food and manufacture goods. There is enormous
opportunity for Canada’s biotechnology industry and the innovative
solutions it represents.

“Canadian entrepreneurs have built companies using sugars to grow
bio-based green chemicals for plastics, and a technology that captures
carbon dioxide from coal-fired plants, developing solutions for the
growing global population. The impact of a changing climate on crop
growth and increased consumer concerns about food safety, health and
nutrition present new opportunities requiring customized solutions,”
commented Andrew Casey, President and CEO BIOTECanada. “As a whole we
must re-engineer our economies, along with our partners including
governments. Biotech innovation is the key to the re-engineering
process.”

Importantly, biotechnology is becoming more central to supporting the
economic and environmental transformation of Canada’s traditional
economic cornerstone and job intensive industries, namely: forestry;
energy; mining; agriculture; aerospace; manufacturing and resource
management. Biotechnology innovation will support these sectors as they
transform and compete in the emerging global bio-economy.

KEY EVENT:
Title: Global Partnerships to build value chains
and transatlantic opportunities in the Bioeconomy

When: Tuesday July 25, 2017
6:45 AM – 8:30 AM
Palais des
Congress, Montreal

The panel discussion will be focused on promoting research and
industrial partnerships for Canadian participants. It will provide an
opportunity to learn about how Canadian SMEs, global multinational
enterprises and researchers can partner on industrial biotechnology
projects, resulting in increased corporate innovation, increased trade,
export and inward investment into Canada.

Panelists include:
Sandy Marshall, BioIndustrial Innovation Canada
Dirk
Carrez, Executive Director, Biobased Industries Consortium
Evan
Price, CEO, CO2 Solutions
Mark Kirby, CEO, S2G BioChem

Contacts

BIOTECanada
Nadine Lunt, 613-230-5585 x257